Effects of Rebonding Technique and Final Cure in Post-operative Hypersensitivity in Class 1 Composite Restorations
Launched by FOUNDATION UNIVERSITY ISLAMABAD · Jun 19, 2025
Trial Information
Current as of June 30, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Rebonding technique has been suggested to address the issue of post-operative hypersensitivity in composite restorations. it involves the application of bonding agent on composite restoration following finishing and polishing. bonding agent fills the gap formed by polymerization shrinkage and hence prevent post-operative hypersensitivity
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • class 1 carious lesion in premolar and molars clinically diagnosed as moderate occlusal caries extending up to middle third of dentin no caries on any other surface of tooth patients with sign and symptom of reversible pulpitis like sharp pain, sensitivity to hot and cold and sweet stimuli lasting foe few seconds
- Exclusion Criteria:
- • history of generalized sensitivity cavities extending up to pulpal third of dentin cavities need to be restored with direct or indirect pulp capping poor oral hygiene or periodontal disease bruxism and other wear facets chronic anti inflammatory, analgesics or psychotropic drugs
About Foundation University Islamabad
Foundation University Islamabad (FUI) is a prominent educational institution dedicated to advancing research and innovation in various fields, including clinical sciences. With a commitment to excellence in education and healthcare, FUI fosters a collaborative environment that encourages multidisciplinary research initiatives. The university actively engages in clinical trials aimed at improving patient outcomes and contributing valuable insights to the medical community. Through its state-of-the-art facilities and a team of experienced professionals, Foundation University Islamabad strives to uphold the highest ethical standards in clinical research, ensuring the integrity and reliability of its findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Islamabad, Federal, Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported